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SERCA2-Controlled Ca2þ -Dependent Keratinocyte
Adhesion and Differentiation Is Mediated via the
Sphingolipid Pathway: A Therapeutic Target for
Darier’s Disease
Anna Celli1,2, Donald S. Mackenzie1,2, Yongjiao Zhai1,2, Chia-Ling Tu3, Daniel D. Bikle3,
Walter M. Holleran2, Yoshikazu Uchida2 and Theodora M. Mauro1,2
Darier’s disease (DD), caused by mutations in the endoplasmic reticulum (ER) Ca2þ ATPase ATP2A2 (SERCA2b),
is a skin disease that exhibits impaired epidermal cell-to-cell adhesion and altered differentiation. Although
previous studies have shown that keratinocyte Ca2þ sequestration and fluxes are controlled by sphingolipid
signaling, the role of this signaling pathway in DD previously has not been investigated. We show here that
sphingosine levels increase and sphingosine kinase (SPHK1) expression decreases after inactivating SERCA2b
with the specific SERCA2 inhibitors thapsigargin (TG) or small interfering RNA to SERCA2b. Conversely,
inhibiting sphingosine lyase rescues the defects in keratinocyte differentiation, E-cadherin localization,
desmoplakin (DP) translocation, and ER Ca2þ sequestration seen in TG-treated keratinocytes. Here, we report
early evidence that the keratinocyte sphingolipid and Ca2þ signaling pathways intersect in ATP2A2-controlled
ER Ca2þ sequestration, E-cadherin and DP localization, and Ca2þ -controlled differentiation, and thus may be
important mediators in DD.
Journal of Investigative Dermatology (2012) 132, 1188–1195; doi:10.1038/jid.2011.447; published online 26 January 2012
INTRODUCTION
Darier’s disease (DD; White, 1889; Darier, 2000) is an
inherited skin disease characterized by keratotic papules and
plaques found mostly in skin flexures and on the chest, upper
back, face, and scalp. Histopathology of DD skin reveals
impaired differentiation, acantholysis, and pathologic apopto-
sis. Patients with DD have also been reported to suffer from
neuropsychiatric disease (Gordon-Smith et al., 2010). Muta-
tions in the endoplasmic reticulum (ER) Ca2þ ATPase (gene
ATP2A2; protein SERCA2b), which sequesters Ca2þ in the
ER, cause DD (Sakuntabhai et al., 1999a, b). The disease is
thought to be caused by haploinsufficiency (Foggia et al.,
2006). Treatment for DD largely has been empiric, and is
only partially effective in some patients, although a variety of
pharmacological and physical agents have been proposed
(Kragballe, 1995; Cooper and Burge, 2003; Reuter et al.,
2007; Stewart and Yell, 2008).
Ca2þ signaling is implicated in keratinocyte and epidermal
differentiation, cell-to-cell adhesion, and apoptosis. Normal
Ca2þ signaling requires both IP3-mediated ER and Golgi Ca2þ
release and Ca2þ influx through Ca2þ -permeable ion channels,
leading to transcription of differentiation-specific genes (Bikle
et al., 2001) and stimulating formation of adherens junctions
containing E-cadherin (Green et al., 2010). Well known as a
structural protein, E-cadherin also recently has been shown to
have important signaling functions, as two kinases contained
within the E-cadherin complex (Xie and Bikle, 2007; Xie et al.,
2009) maintain the prolonged Ca2þ increase essential for
calcium-induced differentiation.
Sphingolipid metabolism (Figure 1a) constitutes a com-
plementary Ca2þ signaling system in keratinocytes. Height-
ened levels of intracellular sphingosine-1-phosphate (S1P)
increase cytosolic Ca2þ levels by direct mobilization of
Ca2þ from thapsigargin (TG)-sensitive stores (Meyer zu
Heringdorf et al., 2003), whereas increases in extracellular
S1P concentrations activate Store-Operated Calcium Entry,
through activation of G-protein-coupled receptors (Mehta
et al., 2005). In keratinocytes, increased intracellular S1P
enhances keratinocyte growth and differentiation, and blocks
apoptosis (Hong et al., 2008; Lichte et al., 2008). Activating
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sphingosine kinase (SPHK1) increases intracellular S1P; thus,
agents that activate this enzyme enhance expression of the
differentiation markers filaggrin and involucrin in HaCAT
keratinocytes (Hong et al., 2008). In contrast, blocking
SPHK1 increases apoptosis in UVB-treated keratinocytes
(Uchida et al., 2010). S1P levels also can be increased by
preventing S1P breakdown (Figure 1a) via sphingosine phos-
phate lyase (SGPL1; reviewed by Kumar and Saba, 2009).
We show here that the sphingolipid and Ca2þ signaling
pathways intersect in controlling SERCA2–ER Ca2þ seques-
tration. SERCA2b inhibition decreases SPHK1 expression
and reproduces the defects in cell growth, adhesion, and
differentiation seen in DD. In contrast, inhibiting SGPL1
compensates for decreased SPHK1 and rescues or amelio-
rates defects in differentiation, E-cadherin processing, des-
moplakin (DP) translocation, and ER Ca2þ sequestration.
Currently, SGPL1 is being targeted as a possible therapeutic
target for rheumatologic disease and multiple sclerosis.
These therapeutic agents could also prove valuable as
therapy for DD.
RESULTS AND DISCUSSION
Increased sphingosine can enhance cell death/cell cycle
arrest, previously reported in a canine model of DD (Muller
et al., 2006), whereas increased levels of S1P promote cell
growth and viability. The relative amounts of these lipids are
determined by the activity of SPHK1, which metabolizes
sphingosine to S1P, and SGPL1, which degrades S1P to
phosphoethanolamine and hexadecanol (Figure 1a). Because
abnormal sphingolipid signaling and DD share impaired cell
differentiation, cell survival, and calcium signaling, we first
examined whether pharmacologically inactivating the ER
Ca2þ ATPase SERCA2b could alter sphingolipid metabolism.
We found that low concentrations of TG (100 nM) increased
sphingosine concentrations (Figure 1b). We were able to
detect decreased sphingosine kinase mRNA expression after
treatment with even lower TG concentrations (10–100 nM;
Figure 1c). A similar decrease in SPHK1 expression was seen
after inactivating SERCA2b with small interfering RNA
(siRNA, Figure 1c). Both siRNA and TG were used to impair
SERCA2 function in subsequent experiments. The dose of
SERCA2b siRNA used for these experiments was chosen to
reproduce the average 50% reduction in SERCA2b expression
seen in DD patients (Foggia et al., 2006; Supplementary
Figure S1 online). In the same paper, the authors report an
average basal level of ER calcium for DD cells, which is 60%
lower than control, as observed by transient cytosolic
calcium increase after TG exposure. We observed that a
similar decrease in ER calcium was obtained by treating cells
with 10 nM TG (Celli et al., 2010, and Figure 7c), and we
therefore used this concentration for the functional studies
presented in this report.
The ER Ca2þ store is important for normal keratinocyte
signaling and differentiation (Callewaert et al., 2003; Foggia
et al., 2006). Previous experiments demonstrated that early
differentiation protein expression is inhibited by disabling the
ER Ca2þ ATPase (Li et al., 1995a, b). Early differentiation
proteins also are decreased in SERCA2 knockout mouse
keratinocytes (Hong et al., 2010), and defects in E-cadherin
localization have been reported in human DD (Tada and
Hashimoto, 1998). Decreased E-cadherin levels and/or
trafficking may directly lead to decreased cell-to-cell adhe-
sion via impaired formation of adherens junctions and may
additionally impair IP3-mediated keratinocyte Ca2þ signal-
ing because the E-cadherin complex formation in the
membrane is essential for phospholipase C gamma 1 activity
(Xie and Bikle, 2007; Xie et al., 2009). We therefore assessed
whether modulating the sphingolipid pathway could repro-
duce or rescue defects in keratinocyte differentiation and
E-cadherin expression or localization. We observed abnor-
mal keratinocyte morphology and growth 24 hours (data not
shown) and 48 hours after TG treatment (Figure 2d). Inhibi-
tion of SGPL1 with siRNA rescued these defects (Figure 2f).
Western blotting showed that SERCA2 inhibition with TG also
led to defects in involucrin protein synthesis and E-cadherin
protein synthesis and processing. These defects could be
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Figure 1. Sphingosine Metabolism is controlled by SERCA2. (a) Sphingosine metabolism in keratinocytes. (b) SERCA2 inactivation increases sphingosine.
Normal human keratinocytes were treated with TG 100nM for 2 hours. Sphingosine levels were measured with HPLC (see Materials and Methods) 24 and
48hours after TG treatment. Data are presented as the mean±SD. N¼3 for each data point, *Po0.05. (c) SPHK1 expression is decreased after SERCA2
inhibition. Normal human keratinocytes were treated with 10 and 100nM TG for 2 hours, washed, recultured, and harvested at 24 (gray bars) and 48 hours
(black bars). In separate experiments, normal human keratinocytes were treated with siRNA to SERCA2b, and then harvested at 48 hours (marble bars).
Control keratinocytes were treated with TG vehicle or scrambled siRNA (marble bar) and normalized to 1. SPHK1 expression was assessed with reverse
transcription–PCR (see Materials and Methods). CoA, coenzyme A; SERCA2, sarco-endoplasmic reticulum calcium ATPase; S1P, sphingosine-1-phosphate;
siRNA, small interfering RNA; SPHK1, sphingosine kinase; TG, thapsigargin.
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normalized or ameliorated by inhibiting SGPL1 synthesis
(Figure 3). We found that SGPL1 inhibition was more effec-
tive in normalizing the defects in involucrin and E-cadherin
expression caused by lower doses of TG (10 nM) than after
higher (100nM) TG (data not shown), likely because the effects
of SERCA2 inhibition became irreversible at higher doses.
Treatment with exogenous S1P had no effect (Supplementary
Figure S3 online). Vitamin D and cannabinoid analogs also
were ineffective (Supplementary Figure S3 online).
The additional, higher-molecular-weight band seen on
immunoblots after TG treatment suggested that E-cadherin
intracellular processing and localization might also be
disrupted when ER Ca2þ stores were depleted, similar to
what has previously been reported for DD (Hakuno et al.,
2000). To test this, we localized E-cadherin first using an
antibody that selectively binds to the extracellular epitope
(Figure 4a–d). E-cadherin normally responds to raised
extracellular Ca2þ by forming continuous, fine intercellular
strands (Figure 4a). TG treatment led to a dose-dependent
disruption in these cell-to-cell contacts, with E-cadherin
localization becoming coarse and irregular at very low
(10 nM) TG concentrations (Figure 4b), and discontinuous at
100 nM TG concentrations (data not shown). SGPL1 inhibition
normalized E-cadherin localization at 10 nM TG (Figure 2d),
but only partially rescued TG-induced E-cadherin disruption
at the 100 nM dose (not shown). Treatment with scrambled
siRNA had no significant effect (Figure 4c). These data
suggest that E-cadherin is not properly localized to the
plasma membrane after SERCA2 inhibition.
To test whether SERCA2 inhibition led to defective
E-cadherin, we next localized E-cadherin using an antibody
that binds to an intracellular E-cadherin epitope. After raising
extracellular Ca2þ , the vast majority of E-cadherin was found
at cell-to-cell junctions in normal keratinocytes (Figure 4e)
with only punctuate foci of intracellular E-cadherin seen.
After treatment with 10 nM TG, extracellular E-cadherin again
appeared irregular and beaded (Figure 4f). In addition,
perinuclear aggregates of E-cadherin were also seen
(Figure 4f), suggesting that ER Ca2þ depletion leads to
intracellular E-cadherin accumulation. This process also was
dose dependent, and the vast majority of E-cadherin was
localized intracellularly after treatment with 100 nM TG (not
Control
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Figure 2. Defects in keratinocyte morphology, induced by SERCA2
inhibition, are normalized by inhibiting SGPL1. Human keratinocytes were
cultured in growth media containing 0.06mM Ca2þ . When 80% confluent,
some of the cells were transfected with siRNA against SGPL1 for 8 hours, and
then 10nM (final concentration) TG was added. After 2 hours exposure to TG,
cells were washed and fed with growth media containing 1.2mM Ca2þ .
Images were acquired 48hours after raising extracellular Ca2þ . (a) Vehicle-
treated cells showing normal morphology: cells are tightly packed and
flattened after 48 hours in high calcium; (b and c) cells treated with scrambled
siRNA or siRNA against SGPL1 show no morphological difference from
untreated cells. (d) A quantity of 10 nM TG treatment produces larger
keratinocytes that have not flattened. (e) Treatment with scrambled siRNA has
no effect on TG-treated cells. (f) Cells treated with both TG and siRNA to
SGPL1 demonstrate a morphology similar to control keratinocytes. All images
were acquired at the same magnification. The scale bar in panel a indicates
50mm. SERCA2, sarco-endoplasmic reticulum calcium ATPase; SGPL1,
sphingosine phosphate lyase; siRNA, small interfering RNA; TG, thapsigargin.
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Figure 3. Defects in involucrin and E-cadherin synthesis and processing are
normalized by inhibiting SGPL1. Human keratinocytes were cultured and
treated as in Figure 2, above. Cells were harvested 48 hours after raising
extracellular Ca2þ . E-cadherin and involucrin protein levels were assessed
using western blotting (see Materials and Methods). SGPL1, sphingosine
phosphate lyase; siRNA, small interfering RNA; TG, thapsigargin.
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shown). As mentioned above, inhibition of SGPL1 was able
to normalize E-cadherin localization in keratinocytes treated
with 10 nM TG (Figure 4h), but only partially rescued
keratinocytes were treated with the higher 100 nM TG (not
shown). Treatment with scrambled siRNA did not rescue the
defects caused by TG treatment (Figure 4g).
Downregulation of SERCA2b expression by siRNA re-
sulted in a similar pattern of intracellular and extracellular
E-cadherin staining (Figure 5d and j, respectively) that could
be normalized by SGPL1 siRNA treatment (Figure 5e and k).
Treatment with a scrambled siRNA sequence had no effect
(Figure 5f and l).
These studies demonstrate that E-cadherin requires normal
ER Ca2þ stores to properly localize to the plasma membrane,
and that the defects seen in cell-to-cell adhesion in DD may
be due to defective E-cadherin localization.
To further investigate the effects of SERCA2 inactivation on
cell-to-cell junctions, we assessed the effect of 10 nM TG on
DP localization, which also is disrupted following SERCA2
inactivation (Hobbs et al., 2011). In agreement with this
previous report, we also observed DP localization at the cell-
to-cell borders within 3 hours after raising extracellular Ca2þ
in control cells (Figure 6a–c). At 48 hours after raising
extracellular Ca2þ , DP was almost entirely localized to
cell-to-cell borders (Figure 6g–i). Similar to E-cadherin, TG
disrupted DP localization in a dose-dependent manner. Cells
treated with 10 nM TG are shown in Figure 6d and j, and
cells treated with 100 nM TG are shown for comparison in
Supplementary Figure S5 online. DP staining was mostly
intracellular in TG-treated cells. Defects in DP staining and
gaps between cells were noted at both the 3- and 48-hour
time points (Figure 6d and j, respectively). Treatment with
SGPL1 siRNA completely rescued DP localization 48 hours
after calcium switch, but only partially at the earlier 3-h time
point (Figure 6k and e, respectively). Treatment with
scrambled siRNA did not rescue the abnormal DP localiza-
tion (Figure 6c, f, i, and l). SGPL1 siRNA also partially
rescued DP localization in cells treated with 100 nM TG
(Supplementary Figure S5 online).
We used the ER-targeted Ca2þ sensor D1ER to monitor
ER Ca2þ depletion after SERCA2 inhibition, and to assess
whether SGPL1 inhibition could ameliorate this loss.
Figure 7a and b present the data as average Fo¨rster resonance
energy transfer ratios and average calcium concentrations,
respectively. A decrease in Fo¨rster resonance energy transfer
ratio indicates lower Ca2þ concentrations. Fo¨rster resonance
energy transfer ratios were converted into calcium concen-
tration following the protocol in Rudolf et al. (2006). siRNA
transfection alone, with either a scrambled sequence or
SGPL1 siRNA, leads to a small decrease in ER calcium levels.
In agreement with a previous report (Celli et al., 2010),
treatment with 10 nM TG caused a significant drop in ER
calcium concentration in both untreated and scrambled
siRNA-transfected samples. However, treatment with 10 nM
TG had no significant effect on ER Ca2þ in cells pretreated
with SGPL1 siRNA (Figure 7a and b). TG treatment produced
more than a 50% drop in ER Ca2þ concentration in both
untreated keratinocytes and scrambled siRNA-transfected
Extracellular E-cadherin Intracellular E-cadherin
Figure 4. Defects in E-cadherin localization are normalized by inhibiting
SGPL1. (a–d) Keratinocytes cultured in 1.2mM Ca2þ for 48 hours were
stained with an E-cadherin antibody that recognizes an extracellular
epitope. (e–h) Keratinocytes cultured in 1.2mM Ca2þ for 48 hours stained
with an E-cadherin antibody that recognizes an intracellular epitope.
(a and e) Control keratinocytes. (b and f) After treatment with 10 nM TG,
extracellular E-cadherin staining (b) is discontinuous, with filamentous
strands (arrows). (f) Perinuclear accumulation of E-cadherin is seen
(arrows). (c and g) Scrambled siRNA does not rescue intracellular or
extracellular E-cadherin localization (arrows). (d and h) SGPL1 inhibition
with siRNA restores continuous, fine extracellular E-cadherin localization
(d) and reverses the E-cadherin intracellular retention (h) seen after
SERCA2 inhibition with TG. SERCA2, sarco-endoplasmic reticulum
calcium ATPase; SGPL1, sphingosine phosphate lyase; siRNA, small
interfering RNA; TG, thapsigargin.
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keratinocytes (Figure 7c). In contrast, SGPL1 inhibition
prevented this TG-induced Ca2þ loss (Figure 7c). These data
indicate that modulating sphingosine metabolism may
normalize TG-induced abnormalities in keratinocyte differ-
entiation and cell-to-cell adhesion by mitigating ER Ca2þ loss
after SERCA2 inactivation. A quantity of 100 nM TG almost
completely emptied ER Ca2þ stores and could not be rescued
by SGPL1 inhibition (data not shown). SGPL1 inhibition did
not change SERCA2 protein levels or SPHK1 mRNA expres-
sion, suggesting that Ca2þ was normalized by a mechanism
independent of SERCA2 or SPHK1 synthesis (Supplementary
Figures S1 and S2 online).
This report demonstrates that inhibiting SGPL1 rescues ER
Ca2þ depletion-induced defects in keratinocyte differentia-
tion and adhesion, and restores ER Ca2þ stores depleted by
SERCA2 inhibition. How sphingosine metabolism and
SERCA2 Ca2þ signaling interact in directing keratinocyte
adhesion and differentiation is not yet well defined. Certainly,
the actions of exogenous S1P in controlling intracellular
Ca2þ have been studied extensively. However, we found that
exogenous S1P was ineffective in rescuing adhesion and
differentiation defects caused by SERCA2b inactivation
(Supplementary Figure S3 online). These data indicate that
generation of intracellular S1P is essential for rescuing the
DD phenotype. Alternatively, extracellular S1P-stimulated
Ca2þ release from the ER may be blunted when these stores
already are depleted because of SERCA2 dysfunction.
Exposure to increased intracellular S1P levels, on the other
hand, has been shown to increase calcium levels in TG-
sensitive stores and to mobilize calcium from these stores
into the cytosol, independently of the plasma membrane
G-protein-coupled S1P receptor (Meyer zu Heringdorf et al.,
2003; Claas et al., 2010).
In a recent paper, Calloway et al. (2009) found that
treatment of RBL mast cells with sphingosine and its
positively charged analogs inhibited the Ca2þ influx via
Store-Operated Calcium Entry usually seen after TG treat-
ment, by flipping to the inner leaflet of the plasma membrane
and preventing Ora1/CRACM1 from interacting with STIM1.
Thus, SERCA2b inactivation might cause not only ER Ca2þ
depletion but also lead to increased intracellular sphingosine,
via SPHK1 inhibition. The increased sphingosine might then
interfere with Ora/CRACM1/STIM interaction, exacerbating
the low ER Ca2þ caused by SERCA2b loss.
We chose to study the effects of ER calcium depletion and
SGPL1 downregulation on E-cadherin because this protein
Untreated SERCA siRNA
Extracellular E-cadherin
Untreated SERCA siRNA
Intracellular E-cadherin
Figure 5. Defects in E-cadherin localization following downregulation of SERCA2b expression with siRNA are normalized by inhibiting SGPL1.
(a–f) Extracellular E-cadherin staining. (a–c) Untreated, SGPL1 siRNA, and scrambled siRNA-treated control cells show linear, smooth staining at the
cell-to-cell borders. (d) Treatment with SERCA2 siRNA results in rough, discontinuous, filamentous borders, and larger cells similar to TG-treated cells
(compare with Figure 4, above). (e) SGPL1 inhibition with siRNA restores normal E-cadherin localization. (f) Scrambled siRNA has no effect. (g–l) Intracellular
E-cadherin staining. (g–i) Untreated, SGPL1 siRNA, and scrambled siRNA-treated control cells show normal, minimal intracellular retention of E-cadherin.
(j) Cells treated with siRNA to SERCA2b demonstrate more diffuse intracellular staining, irregular cell borders, and larger cells; (k) SGPL1 siRNA treatment
restores normal E-cadherin localization; (l) scrambled siRNA has no effect. SERCA2, sarco-endoplasmic reticulum calcium ATPase; SGPL1, sphingosine
phosphate lyase; siRNA, small interfering RNA; TG, thapsigargin.
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t = 3 Hours after calcium switch t = 48 Hours after calcium switch
T10 Control T10
Figure 6. Defects in desmoplakin (DP) localization, caused by SERCA2 inactivation with TG, are normalized by inhibiting SGPL1. DP staining of
human keratinocytes treated with 10 nM TG, 3 hours (a–f) and 48hours (g–l) after raising extracellular Ca2þ . In control (a), SGPL1 (b), and scrambled
siRNA-treated cells (c), DP accumulation at cell-to-cell borders is evident within 3 hours after raising extracellular Ca2þ . (g–i) At 48 hours after raising
extracellular Ca2þ , DP localizes exclusively at the cell-to-cell borders in control (g), SGPL1 siRNA (h), and scrambled siRNA-treated (i) cells. Treatment
with 10 nM TG reduces DP staining at the cell borders 3 hours after raising extracellular Ca2þ (d), and intracellular retention of DP is evident at
48 hours (j); SGPL1 inhibition with siRNA improves DP localization at 3 hours (e), but complete normalization of DP localization is seen only at
48 hours (k). Scrambled siRNA had no effect (f and l). SERCA2, sarco-endoplasmic reticulum calcium ATPase; SGPL1, sphingosine phosphate
lyase; siRNA, small interfering RNA; TG, thapsigargin.
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Figure 7. Defects in ER Ca2þ sequestration are induced by ER SERCA2 inhibition, and are normalized by inhibiting SGPL1. Primary normal human
keratinocytes were transfected with the ER-targeted Ca2þ sensor D1ER (see Materials and Methods). Cells were also transfected with SGPL1 siRNA or
scrambled siRNA as a control. At 8 hours after siRNA transfection, cells were treated with 10 nM thapsigargin for 2 hours. The cells then were washed,
and incubated in high-calcium media for an additional 24 hours. (a) Average Fo¨rster resonance energy transfer ratio; (b) average ER Ca2þ concentration;
(c) relative Ca2þ changes between control (black bars) and TG-treated cells (gray bars) in untreated, scrambled siRNA, and SGPL1 siRNA-treated samples. Data
are presented as the mean±SEM. N¼15–29 cells from two independent sets of experiments in each group. Significance was calculated using a one-way
analysis of variance. Distributions with Po0.05 were assumed as statistically different. ER, endoplasmic reticulum; SERCA2, sarco-endoplasmic reticulum
calcium ATPase; SGPL1, sphingosine phosphate lyase; siRNA, small interfering RNA; TG, thapsigargin.
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has both a structural function and a role in calcium signaling
(Xie and Bikle, 2007; Xie et al., 2009). Moreover, calcium-
dependent E-cadherin aggregation at cell-to-cell adhesion
points is known to be perturbed in DD (Tada and Hashimoto,
1998). In contrast to a previous study (Hobbs et al., 2011),
our experiments demonstrated that E-cadherin localization
was disrupted after SERCA2 inhibition. This discrepancy may
be explained by the longer time course (24–48 vs. 3 hours)
used in our studies, based on previous findings that E-
cadherin continues to aggregate and complex at cell-to-cell
junctions for at least 7–20 hours (Vasioukhin et al., 2000).
Immunofluorescence micrographs of SERCA2 siRNA-treated
cells harvested 3 hours after calcium switch do not show
significant defects in E-cadherin localization (Supplementary
Figure S4 online) as compared with the longer time points,
thus lending support to this hypothesis.
SGPL1 inhibition also normalized DP trafficking, which
has been implicated in DD (Dhitavat et al., 2003; Hobbs
et al., 2011). These studies suggest that modulating the
sphingolipid pathway may ameliorate the defective cell-to-
cell adhesion that is a hallmark of DD.
We studied cells treated with TG or siRNA against SERCA2
in lieu of DD keratinocytes, as previous studies conducted on
DD keratinocytes revealed a wide heterogeneity in calcium
mobilization in these cells (Foggia et al., 2006). Although
further investigation on the effects of SGPL1 inhibition in DD
cells is needed, we show here that reversing SERCA2
inhibition caused by TG or SERCA2 siRNA ameliorates the
junctional and differentiation defects that are known to
underlie DD pathology.
MATERIALS AND METHODS
Cell culture
Normal human keratinocytes, passage 2–3, were plated in 0.03mM
Caþ 2 154 CF media (Cascade, Life Sciences, NY). For experiments
in which TG was used, cells were treated with either scrambled
siRNA (as a negative control) or siRNA against SGPL1 (Hs_SGPL1_2
Flexitube, Quiagen, Valencia, CA) when 80% confluent. At 8 hours
after siRNA treatment, TG at a final concentration of 10 or 100 nM
was added to some of the cells for 2 hours. The media was then
replaced with 1.2mM Caþ 2 154 CF (Cascade, Life Sciences) to induce
differentiation. For experiments in which siRNA against SERCA2
(silencing sequence: 50-AAGCAGGACATCAATGAGCAA-30)
was used, cells were transfected with siRNA against SERCA2, or a
scrambled siRNA sequence for control, when cells were 60%
confluent and treated with SGPL1 siRNA, or with a scrambled siRNA
for control, 24 hours after. Hyperfect transfection reagent (Quiagen)
was used for all siRNA transfections. Cells were harvested at time
points noted in each figure after TG treatment. Vehicle (for TG) or
scrambled siRNA were used as controls.
ER calcium measurements
Confluent cells (60%) were transfected with D1ER (gift from Prof
Tsien’s laboratory) using Mirrus Keratinocyte Transit lipid reagent,
according to the manufacturer’s protocol. At 24 hours after transfec-
tion, cells were treated with SGPL1 siRNA or scrambled siRNA and
TG as described above. Dual-channel fluorescence measurements
were recorded 24 hours later using a Zeiss LSM Meta confocal
system (Carl Zeiss, NY). Calibration of the Calcium sensitivity
range of the probe and conversion of the Fo¨rster resonance
energy transfer ratio into calcium concentrations was performed
following the protocol in Palmer and Tsien (2006) and Rudolf et al.
(2006).
Sphingosine analysis
Total lipids were extracted from keratinocytes and then sphingoid
bases were converted to o-phthalaldehyde derivatives after dephos-
phorylation with alkaline phosphatase as previously reported (Min
et al., 2002). Sphingoid base o-phthalaldehyde derivatives were
separated on the C18 reverse-phase HPLC column (Luna C18(2),
250 4.6mm, 5mm, Phenomenex, Torrance, CA) using methanol/
water (9:1, v/v) with a 1mlmin1 flow. Fluorescence intensity was
monitored at Ex 360 nm and Em 430nm. The sphingoid base content
was reported as pmol per mg of protein.
Immunohistochemistry
Normal human keratinocytes were treated as described above (see
Cell Culture). Samples were formaldehyde fixed. Cells were stained
with an antibody that stained both intracellular and extracellular
E-cadherin (36/E-Cadherin BD Transduction Laboratories, Sparks,
MD), or only the extracellular epitope of E-cadherin (HECD-1,
Abcam, Cambridge, MA). For desmoplakin immunofluorescence,
we used a mouse mAb (1G4 gift from Dr Kathy Green).
Photomicrographs shown in Figure 4 were taken on a Zeiss 510
Meta confocal microscope (Carl Zeiss). Identical laser power and
detector gain levels were used for all images. Photomicrographs in
Figures 5 and 6 were taken using a Zeiss observer/spinning disk
confocal system (Carl Zeiss). Identical laser power and detector gain
levels were used for all images.
Western blotting
Cells were homogenized, and proteins were isolated using RIPA
buffer (Sigma-Aldrich, Saint Louis, MO) containing protease
inhibitors (Roche Applied Science, Indianapolis, IN). Protein
quantification for equal loading was made with the Thermo
Scientific Pierce’s BCA assay kit. SDS–PAGE and transfer was
performed using NuPAGE Novex 4–12% SDS–PAGE and nitrocellu-
lose membranes according to Invitrogen’s NuPAGE protocol.
Membranes were blocked in PBS with 5% nonfat dry milk and
0.05% Tween-20 and incubated with the following primary
antibodies and dilutions: anti-Involucrin (Sigma-Aldrich) at 1:100,
anti-Ecadherin (Invitrogen, Life Science, NY) at 1:500, and anti-b-
actin-HRP (Sigma-Aldrich) at 1:30,000 anti-SERCA2. Chemilumi-
nescent detection was performed with ECL Plus detection reagent
(Thermo Scientific Pierce, Waltham, MA) using the Fujifilm LAS-
3000 imaging system.
Quantitative PCR
All complementary DNAs were generated using the Roche Applied
Science’s Transcriptor first-strand cDNA synthesis kit. Quantitative
PCR was performed using the TaqMan fast universal PCR master mix
and the ABI 7900HT real-time PCR machine (Applied Biosystems,
Life sciences, NY), and target genes were normalized to glycer-
aldehyde-3-phosphate dehydrogenase (primers and dual-labeled
probes from Applied Biosystems). The following human SPHK1
primers and probes were used: CTGTCTGCTCCGAGGACTG
1194 Journal of Investigative Dermatology (2012), Volume 132
A Celli et al.
A Therapeutic Target for Darier’s Disease
forward, CGTGGTTCTTACACCACTGC reverse, TGACCTGCTACCT
CGGCCGC probe.
Statistical analysis
Data were analyzed using the paired, two-tailed Student’s t-test and
one-way analysis of variance.
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